{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:48:20Z","timestamp":1782924500336,"version":"3.54.5"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s15010-026-02793-z","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:20:39Z","timestamp":1776723639000},"page":"1529-1545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidrug-resistant Klebsiella pneumoniae in oncology intensive care units: selected genetic markers and clinical predictors"],"prefix":"10.1007","volume":"54","author":[{"given":"Aya El","family":"Nahas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed O.","family":"El-Gendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Wassef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Molham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"2793_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/9783031509773_70","author":"A Balakrishna","year":"2023","unstructured":"Balakrishna A, Nahrwold D, Hughes C. Intensive care of cancer patients. Anesth Oncol Surg. 2023. https:\/\/doi.org\/10.1007\/9783031509773_70.","journal-title":"Anesth Oncol Surg."},{"key":"2793_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/1871526523666230725103902","volume":"24","author":"JA Alara","year":"2024","unstructured":"Alara JA, Alara OR. An overview of the global alarming increase of multiple drug resistant: a major challenge in clinical diagnosis. Infect Disord Drug Targets. 2024;24:26\u201342. https:\/\/doi.org\/10.2174\/1871526523666230725103902.","journal-title":"Infect Disord Drug Targets"},{"key":"2793_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10056-1","volume":"24","author":"NA Abdelsalam","year":"2024","unstructured":"Abdelsalam NA, ElBanna SA, Mouftah SF, Cobo-D\u00edaz JF, Shata AH, Shawky SM, et al. Genomic dynamics of high-risk carbapenem-resistant Klebsiella pneumoniae clones carrying hypervirulence determinants in Egyptian clinical settings. BMC Infect Dis. 2024;24:1193. https:\/\/doi.org\/10.1186\/s12879-024-10056-1.","journal-title":"BMC Infect Dis"},{"key":"2793_CR4","doi-asserted-by":"crossref","unstructured":"El-Kholy A, El-Mahallawy HA, Elsharnouby N, Abdel Aziz M, Helmy AM, Kotb R. Landscape of multidrug-resistant gram-negative infections in Egypt: survey and literature review. Infect Drug Resist 2021;1905\u201320.","DOI":"10.2147\/IDR.S298920"},{"key":"2793_CR5","doi-asserted-by":"crossref","unstructured":"Ahmed HK, Molham F, El-Gendy AO, Ahmed MAE-GE-S. Coexistence of carbapenem resistance and hypervirulence in clinical Klebsiella pneumoniae isolates: a molecular and phenotypic analysis. BMC Infect Dis 2025;25:1109.","DOI":"10.1186\/s12879-025-11585-z"},{"key":"2793_CR6","doi-asserted-by":"crossref","unstructured":"ElFeky DS, Awad AR, Mowafy HL, Baddour MM, Hamed RMR. Dissemination of NDM-1 and OXA-48 co-producing carbapenem-resistant Enterobacterales at two tertiary hospitals in Egypt. Egypt J Med Microbiol (ESMM); 2024;33:163\u201374.","DOI":"10.21608\/ejmm.2024.288181.1247"},{"key":"2793_CR7","unstructured":"El-Dabaa E. Carbapenemase producing Enterobacterales clinical isolates from a tertiary care hospital in Egypt. Beni-Suef Univ J Basic Appl Sci."},{"key":"2793_CR8","doi-asserted-by":"crossref","unstructured":"Shawky AM, Tolba S, Hamouda HM. Emergence of New Delhi metallo beta lactamase blaNDM-1 and oxacillinases blaOXA-48 Producing Klebsiella pneumoniae in an Egyptian hospital. Egypt J Microbiol. National Information and Documentation Center (NIDOC), Academy of Scientific 2019;54:25\u201337.","DOI":"10.21608\/ejm.2019.12395.1096"},{"key":"2793_CR9","doi-asserted-by":"crossref","unstructured":"Gamal D, Egea P, El\u00edas C, Fern\u00e1ndez-Mart\u00ednez M, Causse M, P\u00e9rez-Nadales E, et al. High-risk clones and novel sequence type ST4497 of Klebsiella pneumoniae clinical isolates producing different alleles of NDM-type and other carbapenemases from a single tertiary-care centre in Egypt. Int J Antimicrob Agents. Elsevier; 2020;56:106164.","DOI":"10.1016\/j.ijantimicag.2020.106164"},{"key":"2793_CR10","doi-asserted-by":"crossref","unstructured":"Tawfick MM, Alshareef WA, Bendary HA, Elmahalawy H, Abdulall AK. The emergence of carbapenemase bla NDM genotype among carbapenem-resistant Enterobacteriaceae isolates from Egyptian cancer patients. Eur J Clin Microbiol Infect Dis. Springer; 2020;39:1251\u20139.","DOI":"10.1007\/s10096-020-03839-2"},{"key":"2793_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.33073\/pjm-2022-011","volume":"71","author":"A Elbaradei","year":"2022","unstructured":"Elbaradei A, Sayedahmed MS, El-Sawaf G, Shawky SM. Screening of mcr-1 among Gram-negative bacteria from different clinical samples from ICU patients in Alexandria, Egypt: one-year study. Polish J Microbiol. 2022;71:83.","journal-title":"Polish J Microbiol"},{"key":"2793_CR12","unstructured":"Abay GK, Shfare MT, Teklu TG, Kidane KM, Gebremeskel TK, Kahsay AG, et al. Extended-spectrum \u03b2-lactamase production and antimicrobial resistance among Enterobacteriaceae causing clinical infections in africa: a systematic review and meta-analysis (2012\u20132020). Eur J Med Res. Springer; 2025;30:14."},{"key":"2793_CR13","doi-asserted-by":"crossref","unstructured":"Hamadt Allah Elhaj Y. Progress and epidemiology of carbapenem resistant Enterobacteriaceae in Saudi Arabia from 2019 to 2023. Egypt J Heal Care. Ain Shams University, Faculty of Nursing; 2024;15:1745\u201355.","DOI":"10.21608\/ejhc.2024.350917"},{"key":"2793_CR14","doi-asserted-by":"crossref","unstructured":"Thomsen J, Abdulrazzaq NM, Consortium UAEAMRS, Everett DB, Menezes GA, Senok A, et al. Carbapenem resistant Enterobacterales in the United Arab Emirates: a retrospective analysis from 2010 to 2021. Front Public Heal. Frontiers Media SA; 2023;11:1244482.","DOI":"10.3389\/fpubh.2023.1244482"},{"key":"2793_CR15","doi-asserted-by":"crossref","unstructured":"Gashaw Y, Asmare Z, Tigabie M, Sisay A, Getatachew E, Tadesse S, et al. Prevalence of colistin-resistant Enterobacteriaceae isolated from clinical samples in Africa: a systematic review and meta-analysis. BMC Infect Dis. Springer; 2025;25:437.","DOI":"10.1186\/s12879-025-10826-5"},{"key":"2793_CR16","doi-asserted-by":"crossref","unstructured":"Al-Hassan L, Nowbuth AA, Beyene GT, Yeshitela B, Berhe DF, Desta K, et al. A scoping review of antibiotic resistance through a One Health lens. Insights from the Nile Valley: Egypt, Sudan, and Ethiopia. Front Trop Dis. Frontiers Media SA; 2025;6:1629274.","DOI":"10.3389\/fitd.2025.1629274"},{"key":"2793_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jgar.2023.10.008","volume":"35","author":"M Kedi\u0161alet\u0161e","year":"2023","unstructured":"Kedi\u0161alet\u0161e M, Phumuzile D, Angela D, Andrew W, Mae N-F. Epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Enterobacterales in Africa: a systematic review. J Glob Antimicrob Resist Elsevier. 2023;35:297\u2013306.","journal-title":"J Glob Antimicrob Resist Elsevier"},{"key":"2793_CR18","doi-asserted-by":"crossref","unstructured":"Touati A, Mairi A. Epidemiology of carbapenemase-producing Enterobacterales in the Middle East: a systematic review. Expert Rev Anti Infect Ther. Taylor & Francis; 2020;18:241\u201350.","DOI":"10.1080\/14787210.2020.1729126"},{"key":"2793_CR19","doi-asserted-by":"crossref","unstructured":"Zowawi HM, Sartor AL, Balkhy HH, Walsh TR, Al Johani SM, AlJindan RY, et al. Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers. Antimicrob Agents Chemother. American Society for Microbiology 1752 N St., NW, Washington, DC; 2014;58:3085\u201390.","DOI":"10.1128\/AAC.02050-13"},{"key":"2793_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s42506-023-00134-8","volume":"98","author":"N Mohamed","year":"2023","unstructured":"Mohamed N, Ghazal A, Ahmed AAH, Zaki A. Prevalence and determinants of antimicrobial resistance of pathogens isolated from cancer patients in an intensive care unit in Alexandria, Egypt. J Egypt Public Health Assoc. 2023;98:9. https:\/\/doi.org\/10.1186\/s42506-023-00134-8.","journal-title":"J Egypt Public Health Assoc"},{"key":"2793_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12020234","volume":"12","author":"T Karampatakis","year":"2023","unstructured":"Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics Basel. 2023;12:234. https:\/\/doi.org\/10.3390\/antibiotics12020234.","journal-title":"Antibiotics Basel"},{"key":"2793_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e41670","author":"HA Owaid","year":"2025","unstructured":"Owaid HA, Al-Ouqaili MTS. Molecular characterization and genome sequencing of selected highly resistant clinical isolates of Pseudomonas aeruginosa and its association with the clustered regularly interspaced palindromic repeat\/Cas system. Heliyon. 2025. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e41670.","journal-title":"Heliyon"},{"key":"2793_CR23","doi-asserted-by":"publisher","first-page":"001","DOI":"10.56781\/ijsrmd.2024.3.2.0034","volume":"3","author":"NL Edoh","year":"2024","unstructured":"Edoh NL, Chigboh VM, Zouo SJC, Olamijuwon J. Improving healthcare decision-making with predictive analytics: a conceptual approach to patient risk assessment and care optimization. Int J Sch Res Med Dent. 2024;3:001\u201310. https:\/\/doi.org\/10.56781\/ijsrmd.2024.3.2.0034.","journal-title":"Int J Sch Res Med Dent"},{"key":"2793_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.vhri.2023.05.005","volume":"37","author":"T Hofmarcher","year":"2023","unstructured":"Hofmarcher T, Garc\u00eda AM, Wilking N, Lindgren P. The disease burden and economic burden of cancer in 9 countries in the Middle East and Africa. Value Heal Reg Issues. 2023;37:81\u20137.","journal-title":"Value Heal Reg Issues"},{"key":"2793_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s43162-025-00412-1","volume":"37","author":"M El-Kassas","year":"2025","unstructured":"El-Kassas M, Ezzat R, Shousha H, Bosson-Amedenu S, Ouerfelli N. Mapping cancer in Egypt: a model to predict future cancer situation using estimates from GLOBOCAN 2020. Egypt J Intern Med. 2025;37:31 (Springer;).","journal-title":"Egypt J Intern Med"},{"key":"2793_CR26","volume-title":"Report of the 72nd session of the WHO Regional Committee for the Eastern Mediterranean WHO Regional Office, Cairo, Egypt, 15\u201317 October 2025","author":"WH Organization","year":"2026","unstructured":"Organization WH. Report of the 72nd session of the WHO Regional Committee for the Eastern Mediterranean WHO Regional Office, Cairo, Egypt, 15\u201317 October 2025. Regional Office for the Eastern Mediterranean: World Health Organization; 2026."},{"key":"2793_CR27","doi-asserted-by":"publisher","DOI":"10.4137\/CMPed.S16413","volume":"8","author":"ER Abdelkhalek","year":"2014","unstructured":"Abdelkhalek ER, Sherief LM, Kamal NM, Soliman RM. Factors associated with delayed cancer diagnosis in Egyptian children. Clin Med Insights Pediatr. 2014;8:CMPed-S16413 (SAGE Publications Sage UK: London, England;).","journal-title":"Clin Med Insights Pediatr"},{"key":"2793_CR28","doi-asserted-by":"publisher","DOI":"10.21608\/sjns.2025.422330.1096","volume-title":"Characteristics and Outcome of Cancer Patients Admitted to Intensive Care Units","author":"SK Abd Elrady","year":"2025","unstructured":"Abd Elrady SK, Mohamed SS. Characteristics and Outcome of Cancer Patients Admitted to Intensive Care Units. Faculty of Nursing: Sohag J Nurs Sci. Sohag University; 2025."},{"key":"2793_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1373\/clinchem.2014.221770","volume":"61","author":"R Patel","year":"2015","unstructured":"Patel R. MALDI-TOF MS for the diagnosis of infectious diseases. Clin Chem. 2015;61:100\u201311. https:\/\/doi.org\/10.1373\/clinchem.2014.221770.","journal-title":"Clin Chem"},{"key":"2793_CR30","unstructured":"CLSI supplement M100 22nd edition [Internet]. 32ed ed. wayane PA: Clinical and Laboratory Standards Institute; 2022. https:\/\/clsi.org\/media\/1872\/_m100_archived_drugs_table.pdf"},{"key":"2793_CR31","doi-asserted-by":"crossref","unstructured":"Yaghoubi S, Zekiy AO, Krutova M, Gholami M, Kouhsari E, Sholeh M, et al. Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. Eur J Clin Microbiol Infect Dis. Springer; 2022;41:1003\u201322.","DOI":"10.1007\/s10096-020-04121-1"},{"key":"2793_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A Magiorakos","year":"2012","unstructured":"Magiorakos A, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect Wiley Online Library. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect Wiley Online Library"},{"key":"2793_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39730-0","volume":"9","author":"AA Ramadan","year":"2019","unstructured":"Ramadan AA, Abdelaziz NA, Amin MA, Aziz RK. Novel blaCTX-M variants and genotype-phenotype correlations among clinical isolates of extended spectrum beta lactamase-producing Escherichia coli. Sci Rep. 2019;9:4224. https:\/\/doi.org\/10.1038\/s41598-019-39730-0","journal-title":"Sci Rep"},{"key":"2793_CR34","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1093\/nar\/gku1189","volume":"43","author":"Y Xia","year":"2015","unstructured":"Xia Y, Chu W, Qi Q, Xun L. New insights into the QuikChangeTM process guide the use of Phusion DNA polymerase for site-directed mutagenesis. Nucleic Acids Res Oxford University Press. 2015;43:e12\u2013e12.","journal-title":"Nucleic Acids Res Oxford University Press"},{"key":"2793_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep38929","volume":"6","author":"R Wasfi","year":"2016","unstructured":"Wasfi R, Elkhatib WF, Ashour HM. Molecular typing and virulence analysis of multidrug resistant Klebsiella pneumoniae clinical isolates recovered from Egyptian hospitals. Sci Rep. 2016;6:38929. https:\/\/doi.org\/10.1038\/srep38929.","journal-title":"Sci Rep"},{"key":"2793_CR36","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3201\/eid2004.131718","volume":"20","author":"CJH von Wintersdorff","year":"2014","unstructured":"von Wintersdorff CJH, Penders J, Stobberingh EE, Oude Lashof AML, Hoebe CJPA, Savelkoul PHM, et al. High rates of antimicrobial drug resistance gene acquisition after international travel, The Netherlands. Emerg Infect Dis. 2014;20:649.","journal-title":"Emerg Infect Dis"},{"key":"2793_CR37","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1007\/s00284-020-02217-7","volume":"77","author":"MA Yakout","year":"2020","unstructured":"Yakout MA, Ali GH. Multidrug resistance in Integron bearing Klebsiella pneumoniae isolated from Alexandria University Hospitals, Egypt. Curr Microbiol. 2020;77:3897\u2013902. https:\/\/doi.org\/10.1007\/s00284-020-02217-7.","journal-title":"Curr Microbiol"},{"key":"2793_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12223-018-0630-3","volume":"64","author":"S Kiaei","year":"2019","unstructured":"Kiaei S, Moradi M, Hosseini Nave H, Hashemizadeh Z, Taati-Moghadam M, Kalantar-Neyestanaki D. Emergence of co-existence of bla NDM with rmtC and qnrB genes in clinical carbapenem-resistant Klebsiella pneumoniae isolates in burning center from southeast of Iran. Folia Microbiol (Praha). 2019;64:55\u201362.","journal-title":"Folia Microbiol (Praha)"},{"key":"2793_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaf167","author":"VH Krishnaprasad","year":"2025","unstructured":"Krishnaprasad VH, Nayak V, Kumar S. World Health Organisation\u2019s Bacterial Pathogen Priority List (BPPL) 2017 and BPPL 2024 to combat global antimicrobial resistance crisis:\u2018challenges and opportunities.\u2019 J Antimicrob Chemother. 2025. https:\/\/doi.org\/10.1093\/jac\/dkaf167.","journal-title":"J Antimicrob Chemother"},{"key":"2793_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1128\/CMR.11.4.589","volume":"11","author":"R Podschun","year":"1998","unstructured":"Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11:589\u2013603.","journal-title":"Clin Microbiol Rev"},{"key":"2793_CR41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/femsre\/fux013","volume":"41","author":"S Navon-Venezia","year":"2017","unstructured":"Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev 2017;41:252\u201375.","journal-title":"FEMS Microbiol Rev"},{"key":"2793_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-017-0191-3","volume":"16","author":"L Xu","year":"2017","unstructured":"Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16:18.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2793_CR43","doi-asserted-by":"crossref","unstructured":"Borer A, Saidel-Odes L, Riesenberg K, Eskira S, Peled N, Nativ R, et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009;30:972\u20136.","DOI":"10.1086\/605922"},{"key":"2793_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1157010","volume":"13","author":"D Li","year":"2023","unstructured":"Li D, Huang X, Rao H, Yu H, Long S, Li Y, et al. Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2023;13:1157010.","journal-title":"Front Cell Infect Microbiol"},{"key":"2793_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1517\/14740338.2015.997206","volume":"14","author":"Q Kaewpoowat","year":"2015","unstructured":"Kaewpoowat Q, Ostrosky-Zeichner L. Tigecycline: a critical safety review. Expert Opin Drug Saf. 2015;14:335\u201342.","journal-title":"Expert Opin Drug Saf"},{"key":"2793_CR46","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1128\/AAC.01169-07","volume":"52","author":"CG Giske","year":"2008","unstructured":"Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52:813\u201321.","journal-title":"Antimicrob Agents Chemother"},{"key":"2793_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-020-0686-0","volume":"9","author":"WM Zhu","year":"2020","unstructured":"Zhu WM, Yuan Z, Zhou HY. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2020;9:23. https:\/\/doi.org\/10.1186\/s13756-020-0686-0.","journal-title":"Antimicrob Resist Infect Control"},{"key":"2793_CR48","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2174\/1386207324666210121104724","volume":"25","author":"SM Refay","year":"2022","unstructured":"Refay SM, Ahmed EH, Abd ELzaher AR, Morsy AM, Yasser MM, Mahmoud AM. Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients. Comb Chem High Throughput Screen. 2022;25:324\u201334.","journal-title":"Comb Chem High Throughput Screen"},{"key":"2793_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-019-0343-8","volume":"19","author":"CY Effah","year":"2020","unstructured":"Effah CY, Sun T, Liu S, Wu Y. Klebsiella pneumoniae: an increasing threat to public health. Ann Clin Microbiol Antimicrob. 2020;19:1.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2793_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1086\/313590","volume":"30","author":"A Asensio","year":"2000","unstructured":"Asensio A, Oliver A, Gonz\u00e1lez-Diego P, Baquero F, P\u00e9rez-D\u00edaz JC, Ros P, et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis. 2000;30:55\u201360.","journal-title":"Clin Infect Dis"},{"key":"2793_CR51","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S0140-6736(72)92084-3","volume":"300","author":"M Pollack","year":"1972","unstructured":"Pollack M, Nieman R, Reinhardt J, Charache P, Jett M, Hardy JRP. Factors influencing colonisation and antibiotic-resistance patterns of gram-negative bacteria in hospital patients. Lancet Elsevier. 1972;300:668\u201371.","journal-title":"Lancet Elsevier"},{"key":"2793_CR52","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/jac\/dkr116","volume":"66","author":"EI Kritsotakis","year":"2011","unstructured":"Kritsotakis EI, Tsioutis C, Roumbelaki M, Christidou A, Gikas A. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-\u03b2-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case\u2013control study. J Antimicrob Chemother Oxford University Press. 2011;66:1383\u201391.","journal-title":"J Antimicrob Chemother Oxford University Press"},{"key":"2793_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jmii.2011.09.026","volume":"45","author":"S-W Liu","year":"2012","unstructured":"Liu S-W, Chang H-J, Chia J-H, Kuo A-J, Wu T-L, Lee M-H. Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study. J Microbiol Immunol Infect. 2012;45:113\u20139.","journal-title":"J Microbiol Immunol Infect"},{"key":"2793_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/infdis\/jit157","volume":"208","author":"Y-T Lin","year":"2013","unstructured":"Lin Y-T, Liu C-J, Yeh Y-C, Chen T-J, Fung C-P. Ampicillin and amoxicillin use and the risk of Klebsiella pneumoniae liver abscess in Taiwan. J Infect Dis. 2013;208:211\u20137.","journal-title":"J Infect Dis"},{"key":"2793_CR55","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"NN Keum","year":"2019","unstructured":"Keum NN, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16:713\u201332. https:\/\/doi.org\/10.1038\/s41575-019-0189-8.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2793_CR56","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nature25973","volume":"555","author":"D Rothschild","year":"2018","unstructured":"Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555:210\u20135.","journal-title":"Nature"},{"key":"2793_CR57","doi-asserted-by":"crossref","unstructured":"Yu J, Feng Q, Wong SH, Zhang D, yi Liang Q, Qin Y, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. BMJ 2017;66:70\u20138.","DOI":"10.1136\/gutjnl-2015-309800"},{"key":"2793_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016393","volume":"6","author":"I Sobhani","year":"2011","unstructured":"Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE. 2011;6:e16393.","journal-title":"PLoS ONE"},{"key":"2793_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174146","volume":"20","author":"I Koliarakis","year":"2019","unstructured":"Koliarakis I, Messaritakis I, Nikolouzakis TK, Hamilos G, Souglakos J, Tsiaoussis J. Oral bacteria and intestinal dysbiosis in colorectal cancer. Int J Mol Sci. 2019;20:4146.","journal-title":"Int J Mol Sci"},{"key":"2793_CR60","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00626-22","volume":"8","author":"MTF Lamaudi\u00e8re","year":"2023","unstructured":"Lamaudi\u00e8re MTF, Arasaradnam R, Weedall GD, Morozov IY. The colorectal cancer gut environment regulates activity of the microbiome and promotes the multidrug resistant phenotype of ESKAPE and other pathogens. mSphere. 2023;8:e00626-22.","journal-title":"mSphere"},{"key":"2793_CR61","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.jfma.2021.04.014","volume":"120","author":"J-Y Hsu","year":"2021","unstructured":"Hsu J-Y, Chuang Y-C, Wang J-T, Chen Y-C, Hsieh S-M. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017\u20132019. J Formos Med Assoc. 2021;120:1994\u20132002.","journal-title":"J Formos Med Assoc"},{"key":"2793_CR62","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10096-021-04392-2","volume":"41","author":"B Kayaaslan","year":"2022","unstructured":"Kayaaslan B, Oktay Z, Hasanoglu I, Kalem AK, Eser F, Ayhan M, et al. Increasing rates of extended-spectrum B-lactamase-producing Escherichia coli and Klebsiella pneumoniae in uncomplicated and complicated acute pyelonephritis and evaluation of empirical treatments based on culture results. Eur J Clin Microbiol Infect Dis. 2022;41:421\u201330.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2793_CR63","doi-asserted-by":"publisher","DOI":"10.1086\/533452","author":"LB Rice","year":"2008","unstructured":"Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008. https:\/\/doi.org\/10.1086\/533452.","journal-title":"J Infect Dis"},{"key":"2793_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1\u201312.","journal-title":"Clin Infect Dis"},{"key":"2793_CR65","doi-asserted-by":"crossref","unstructured":"Mukherjee S, De MS, Goel G, Bhattacharyya A, Mallick I, Dabkara D, et al. Multi-drug resistant (MDR) and extensively drug-resistant (XDR) bacteraemia rates among cancer patients in an oncology hospital in eastern India: an 11-year retrospective observational study. Infect Prev Pract. 2023;5:100275.","DOI":"10.1016\/j.infpip.2023.100275"},{"key":"2793_CR66","doi-asserted-by":"crossref","unstructured":"Lin X, Li C, Zhang S, Yang X, Jiang M. The global and regional prevalence of hospital-acquired carbapenem-resistant Klebsiella pneumoniae infection: a systematic review and meta-analysis. Open forum Infect Dis 2024. ofad649.","DOI":"10.1093\/ofid\/ofad649"},{"key":"2793_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-024-01497-z","volume":"13","author":"A Azzam","year":"2024","unstructured":"Azzam A, Khaled H, Samer D, Nageeb WM. Prevalence and molecular characterization of ESBL-producing Enterobacteriaceae in Egypt: a systematic review and meta-analysis of hospital and community-acquired infections. Antimicrob Resist Infect Control. 2024;13:145. https:\/\/doi.org\/10.1186\/s13756-024-01497-z.","journal-title":"Antimicrob Resist Infect Control"},{"key":"2793_CR68","doi-asserted-by":"crossref","unstructured":"Rodrigues RS, Carvalho AG, Silva MEP, Ramos IVG, Lima NCS, Esquerdo RP, et al. Antibiotic resistance and biofilm formation in Klebsiella spp. isolates from Intensive Care Units in the Brazilian Amazon. Brazilian J Biol. Sci 2024;84:e286461.","DOI":"10.1590\/1519-6984.286461"},{"key":"2793_CR69","unstructured":"Aitken SL, Clancy CJ. IDSA Guidance on the treatment of antimicrobial resistant gram-negative infections. MJH Life Sci 2020."},{"key":"2793_CR70","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/jac\/dkr242","volume":"66","author":"D Yahav","year":"2011","unstructured":"Yahav D, Lador A, Paul M, Leibovici L. Efficacy and safety of tigecycline: a systematic review and meta-analysis. J Antimicrob Chemother. 2011;66:1963\u201371.","journal-title":"J Antimicrob Chemother"},{"key":"2793_CR71","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1054\/drup.2000.0146","volume":"3","author":"O Sk\u00f6ld","year":"2000","unstructured":"Sk\u00f6ld O. Sulfonamide resistance: mechanisms and trends. Drug Resist Updat. 2000;3:155\u201360. https:\/\/doi.org\/10.1054\/drup.2000.0146.","journal-title":"Drug Resist Updat"},{"key":"2793_CR72","doi-asserted-by":"crossref","unstructured":"Wong MHY, Chan EWC, Chen S. Evolution and dissemination of OqxAB-like efflux pumps, an emerging quinolone resistance determinant among members of Enterobacteriaceae. Antimicrob Agents Chemother. American Society for Microbiology 1752 N St., NW, Washington, DC; 2015;59:3290\u20137.","DOI":"10.1128\/AAC.00310-15"},{"key":"2793_CR73","doi-asserted-by":"crossref","unstructured":"Jacoby GA, Strahilevitz J, Hooper DC. Plasmid\u2010mediated quinolone resistance. Plasmids Biol Impact Biotechnol Discov. Wiley Online Library; 2015;475\u2013503.","DOI":"10.1128\/9781555818982.ch25"},{"key":"2793_CR74","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Mart\u00ednez JM, D\u00edaz de Alba P, Briales A, Machuca J, Lossa M, Fern\u00e1ndez-Cuenca F, et al. Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum-\u03b2-lactamase-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2013;68:68\u201373.","DOI":"10.1093\/jac\/dks377"},{"key":"2793_CR75","doi-asserted-by":"crossref","unstructured":"Mustafa MS, Abdullah RM. Role of oqxA and oqxB Genes in the Development of Multidrug Resistant Phenotype among Clinical Klebsiella pneumoniae Isolates from Various Cases. Iraqi J Sci. 2020;1902\u201312.","DOI":"10.24996\/ijs.2020.61.8.7"},{"key":"2793_CR76","unstructured":"Albarri O, AlMatar M, Var I, K\u00f6ksal F. Antimicrobial resistance of clinical Klebsiella pneumoniae isolates: involvement of AcrAB and OqxAB efflux pumps. Curr Mol Pharmacol. 2024;17:E310323215266."},{"key":"2793_CR77","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s40588-023-00211-8","volume":"10","author":"I Gogoi","year":"2023","unstructured":"Gogoi I, Puzari M, Chetia P. Porin-mediated carbapenem resistance in klebsiella pneumoniae: an alarming threat to global health. Curr Clin Microbiol Reports. 2023;10:255\u201365.","journal-title":"Curr Clin Microbiol Reports"},{"issue":"7","key":"2793_CR78","doi-asserted-by":"publisher","DOI":"10.1128\/jb.00148-25","volume":"207","author":"Y Su","year":"2025","unstructured":"Su Y, Zou G, Huang X, Bi J, Meng L, Zhao W, et al. Molecular characterization and resistance mechanisms of ertapenem-non-susceptible carbapenem-resistant Klebsiella pneumoniae co-harboring ESBLs or AmpC enzymes with porin loss or efflux pump overexpression. J Bacteriol. 2025;207(7):e00148-25. https:\/\/doi.org\/10.1128\/jb.00148-25.","journal-title":"J Bacteriol"},{"key":"2793_CR79","first-page":"39","volume":"5","author":"M Moghadasi","year":"2016","unstructured":"Moghadasi M, Mirzaee M, Mehrabi MR. Frequency of quinolone resistance and qnrb and qnrc genes in clinical isolates of Klebsiella pneumoniae. J Med Bacteriol. 2016;5:39\u201345.","journal-title":"J Med Bacteriol"},{"key":"2793_CR80","doi-asserted-by":"crossref","unstructured":"Wyres KL, Lam MMC, Holt KE. Population genomics of Klebsiella pneumoniae. Nat Rev Microbiol. Nature. 2020;18:344\u201359.","DOI":"10.1038\/s41579-019-0315-1"},{"key":"2793_CR81","unstructured":"Organization WH. Global report on infection prevention and control 2024. World Health Organization; 2024."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02793-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02793-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02793-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:52:19Z","timestamp":1782921139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-026-02793-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2793"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02793-z","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study protocol was approved by the Human Research Ethical Committee of the Faculty of Pharmacy, Beni-Suef University (approval number: F PH-BSU-HREC-000725). The requirement for informed consent was waived by the Human Research Ethical Committee of the Faculty of Pharmacy, Beni-Suef University, as the clinical isolates were collected as part of routine hospital laboratory procedures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}